Showing results (41-50 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|August 14, 2023
Five-year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospective studyDennis Bomansang Daliri, Agani Afaya, Timothy Tienbia Laari, et al.
Neuropsychopharmacology Reports|July 18, 2023
Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic reviewYoshitaka Kawashima, Misa Yamada, Hiroki Furuie, et al.
Neuropsychopharmacology Reports|June 27, 2023
Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trialTakuhiro Sonoyama, Ryosuke Shimizu, Ryuji Kubota, et al.
Neuropsychopharmacology Reports|June 21, 2023
Sex differences in the characteristics of stimulant offenders with a history of substance use disorder treatmentAyumi Kondo, Takuya Shimane, Masaru Takahashi, et al.
Neuropsychopharmacology Reports|February 6, 2020
Development of the Interpersonal Processes of Care Survey-Japanese versionTakuma Shiozawa, Sosei Yamaguchi, Asami Matsunaga, et al.
Neuropsychopharmacology Reports|October 22, 2020
Visually cued fear conditioning test for memory impairment related to cortical functionKazuya Kuboyama, Yuki Shirakawa, Koji Kawada, et al.
Neuropsychopharmacology Reports|September 16, 2020
Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin-evoked dopamine release in ratsDominic P Isaacs, Ryan P Leman, Thomas J Everett, et al.
Neuropsychopharmacology Reports|December 4, 2019
Microglia attenuate the kainic acid-induced death of hippocampal neurons in slice culturesTasuku Araki, Yuji Ikegaya, Ryuta Koyama
Pageof 66